血栓形成是否在缺陷性中风和脑小血管疾病中起因作用?
Fatemeh Koohi1, Eric L Harshfield1, Alexey Shatunov1
1Department of Clinical Neurosciences, Stroke Research Group, University of Cambridge, United Kingdom.
Stroke
|March 25, 2024
概括
对静脉血栓的遗传倾向增加了心血管栓塞和大动脉中风的风险,但不是缺口中风 (LS) 或脑小血管疾病 (cSVD) 标志物. 这表明抗血栓治疗对LS可能不那么有效.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 心血管医学 心血管医学
背景情况:
- 血栓塞栓症在性中风 (LS) 发病过程中的作用,这是大脑小血管疾病 (cSVD) 的结果,仍在争论中.
- 目前对LS的二次预防策略通常涉及抗血小板治疗,但在明确的患者队列中,强有力的试验证据有限.
研究的目的:
- 通过两样本的孟德尔随机化方法,研究LS和cSVD中改变抗凝的因果作用.
- 评估静脉血栓形成的遗传倾向与不同中风亚型和cSVD标志物的风险之间的关联.
主要方法:
- 从一个大型全基因组关联研究中利用了119个与静脉血栓相关的遗传变异作为仪器变量.
- 使用来自GIGASTROKE联盟的缺血性中风亚型 (心血管,大动脉,LS) 的遗传关联数据.
- 包括磁共振成像证实LS病例的数据,并分析了与白质超强度和cSVD扩散张力成像指标的关联.
主要成果:
- 对静脉血栓的遗传倾向与任何缺血性中风,心血栓性中风和大动脉中风的几率增加显著相关.
- 在GIGASTROKE或MRI确认的队列中,对静脉血栓形成的遗传风险和缺口性中风 (LS) 之间没有发现显著的关联.
- 基因预测的静脉血栓形成风险与脑小血管疾病 (cSVD) 的成像标志物无关.
结论:
- 改变的血栓形成似乎是心血管栓塞和大动脉中风的因果因素,但不是LS或cSVD.
- 这些发现表明,抗血栓性药物可能降低了对治疗cSVD的疗效.
- 需要进行进一步的临床试验,以评估各种抗血栓治疗方案的有效性,特别是在特征良好的LS患者队列中.
相关概念视频
Clot Retraction and Fibrinolysis
5.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885


